<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Tension-type headache in adults: Etiology, clinical features, and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Tension-type headache in adults: Etiology, clinical features, and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Tension-type headache in adults: Etiology, clinical features, and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Frederick R Taylor, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jerry W Swanson, MD, MHPE
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Richard P Goddeau, Jr, DO, FAHA
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 08, 2024.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Tension-type headache (TTH) is a primary headache disorder characterized by a bilateral, nonthrobbing headache of a mild to moderate intensity, typically without other associated features. TTH is the most common headache and prevalent neurologic disorder in the population. Due to its high prevalence, TTH causes a high burden of disability.
        </p>
        <p>
         TTH was previously known by several other terms that referred to its suspected etiology, including stress headache, tension headache, muscle-contraction headache, psychomyogenic headache, and psychogenic headache [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         This topic will review the etiology, epidemiology, clinical features, and diagnosis of TTH in adults. Other aspects of TTH are discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3358.html" rel="external">
          "Tension-type headache in adults: Acute treatment"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3360.html" rel="external">
          "Tension-type headache in adults: Preventive treatment"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6160.html" rel="external">
          "Tension-type headache in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3257919758">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Headache is one of the most common reasons for neurologic consultation, and TTH is the most prevalent type of primary headache in the general population [
         <a href="#rid2">
          2-4
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevalence
         </strong>
         – The worldwide prevalence of TTH was estimated in 2016 to be 26 percent in the Global Burden of Disease Study [
         <a href="#rid5">
          5
         </a>
         ]. However, prevalence estimates of TTH vary by methodology, patient age, and specific population studied. In a telephone survey of individuals age 18 to 65, the one-year prevalence of episodic TTH in the United States was 38 percent [
         <a href="#rid6">
          6
         </a>
         ]. In a population-based Danish twin registry, the one-year prevalence of TTH among 12- to 41-year-old subjects was 86 percent [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Reported TTH prevalence also varies when stratified by headache frequency. TTH may be classified as infrequent episodic headache, frequent episodic headache, and chronic headache, based on monthly average headache occurrence of &lt;1, 1 to 14, or ≥15 attacks, respectively. Most patients with TTH have the infrequent episodic subtype [
         <a href="#rid4">
          4
         </a>
         ]. Using the International Classification of Headache Disorders, 2nd edition (ICHD-2) criteria to classify TTH subtypes, the Danish twin registry found that the one-year-period prevalences of infrequent episodic TTH, frequent episodic TTH, and chronic TTH were 63.5, 21.6, and 0.9 percent, respectively [
         <a href="#rid7">
          7
         </a>
         ]. An earlier population study from the United States found that the one-year prevalences of episodic and chronic TTH were 38.3 and 2.2 percent [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The prevalence of TTH may be underreported because only a small percentage of persons with mild and/or infrequent TTH seek medical care for this diagnosis. In fact, some experts regard the infrequent episodic subtype of TTH not as a disease, but as an expected, normal phenomenon that does not require medical attention in many instances [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Limited data suggest that White Americans have a higher prevalence of TTH compared with Black Americans [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Role of sex and age
         </strong>
         – Females appear to have a slightly higher prevalence of TTH than males. In a Danish population study, the lifetime prevalence of episodic TTH in females and males was 99 and 69 percent, respectively [
         <a href="#rid9">
          9
         </a>
         ]. A female predominance is more apparent with increased frequency of headache attacks. In another Danish population-based study that evaluated 4000 40-year-old subjects, males were slightly more likely to have infrequent episodic TTH, while females were more likely to have both frequent episodic TTH (43 versus 25 percent) and chronic TTH (3 versus 1 percent) [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Data regarding age dependence of TTH are limited. In data from the Global Burden of Disease Study, the prevalence of TTH was found to sharply increase during adolescence, peak in the fourth decade of life, and gradually decrease thereafter [
         <a href="#rid5">
          5
         </a>
         ]. Similar results were found in a population-based study from the United States [
         <a href="#rid6">
          6
         </a>
         ]. A Danish study found a decreasing prevalence of TTH with increasing age [
         <a href="#rid9">
          9
         </a>
         ]. However, other studies have shown that TTH continues to be a problem for many older patients, occurring in 20 to 30 percent of those over 60 years of age [
         <a href="#rid6">
          6,11,12
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Burden of disease
         </strong>
         – The societal burden of TTH is high. In one population study, individuals with episodic TTH reported a mean of nine work days lost and another five reduced-effectiveness days per year, while persons with chronic TTH reported a yearly mean of 27 lost work days and 20 reduced-effectiveness days [
         <a href="#rid6">
          6
         </a>
         ]. A cross-sectional population study found TTH was associated with reductions in several measures of health-related quality of life [
         <a href="#rid13">
          13
         </a>
         ]. The burden is particularly high for the subset of patients who have substantial and complicating comorbidities, such as hypertension, cardiovascular disease, and depression [
         <a href="#rid14">
          14
         </a>
         ]. The impact of TTH appears to be greatest on those who continue to be symptomatic into their older years of life [
         <a href="#rid6">
          6,11,12
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          ETIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The etiology of TTH is probably multifactorial, but the precise mechanisms are uncertain [
         <a href="#rid15">
          15
         </a>
         ]. Environmental factors such as stress and muscle tenderness appear to be most impactful in the development of episodic TTH, while genetic factors appear to play a key role in development of chronic TTH [
         <a href="#rid16">
          16-18
         </a>
         ]. However, the wide variation in frequency and intensity in TTH suggests that the underlying pain mechanisms and contributing factors have dynamic and variable roles in the pathogenesis of TTH, both from one individual to another and from one attack to another in the same individual.
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Pathogenesis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Peripheral activation or sensitization of myofascial nociceptors is most likely a major contributor to the development of episodic TTH. In addition, continuous nociceptive input from peripheral myofascial structures may induce central sensitization and lead to the conversion of episodic to chronic TTH [
         <a href="#rid15">
          15,19-23
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h3">
          Central factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Heightened sensitivity of pain pathways in the central nervous system is thought to play a critical role in the pathogenesis of TTH [
         <a href="#rid24">
          24-26
         </a>
         ].
        </p>
        <p>
         General pain sensitivity in the central nervous system is increased in chronic TTH. There may be a lack of habituation as evidenced by recording sympathetic skin responses compared with normal controls [
         <a href="#rid25">
          25,27-29
         </a>
         ]. Decreased pain, thermal, and electrical thresholds reported in patients with chronic TTH probably represent a central misinterpretation of incoming signals [
         <a href="#rid30">
          30-32
         </a>
         ].
        </p>
        <p>
         Sustained pericranial myofascial input may increase excitability of the central nervous system. This neuronal excitability may result in increased facilitation and decreased inhibition of pain transmission at the level of the spinal dorsal horn/trigeminal nucleus and may further promote increased pericranial muscle activity. Altered brainstem nociceptive reflex findings (eg, reduced subjective pain and reflex thresholds) suggest that limbic-controlled descending pain systems may be abnormal due to deficient descending inhibition in patients with chronic TTH [
         <a href="#rid33">
          33-35
         </a>
         ].
        </p>
        <p>
         Centrally acting molecular factors have also been implicated in the pathogenesis of TTH. Nitric oxide has been shown to induce TTH, and nitric oxide synthetase inhibition has been shown to reduce TTH intensity [
         <a href="#rid36">
          36,37
         </a>
         ]. Modest reductions in serum N-acetyl-aspartate (a marker of neuronal dysfunction) and serum brain-derived neurotropic factor (which interacts with calcitonin gene-related peptide) have also been reported in patients with TTH [
         <a href="#rid38">
          38,39
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h3">
          Peripheral factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Firm evidence for peripheral sources of TTH is unavailable, but muscular factors may be important, especially in episodic TTH [
         <a href="#rid23">
          23,25
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Myofascial trigger points
         </strong>
         – Compared with matched control subjects without headache, subjects with episodic TTH demonstrate more active and latent trigger points, lower pain threshold at nerve trunks, forward head posture, and reduced neck mobility [
         <a href="#rid40">
          40-43
         </a>
         ]. Increased muscle tenderness is the most pronounced and consistent finding in TTH patients and probably represents the activation of peripheral nociceptors [
         <a href="#rid44">
          44
         </a>
         ]. The intensity and frequency of TTH positively correlates with pericranial muscle tenderness [
         <a href="#rid15">
          15
         </a>
         ]. Although the origin of muscle tenderness is unknown, nociceptors around blood vessels in striated muscle, tendon insertions, and fascia have been suggested as sources of the pain [
         <a href="#rid25">
          25,26
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Inflammation
         </strong>
         – Peripherally mediated neurovascular inflammation may contribute to the development of TTH. Elevated levels of several inflammatory mediators (interleukin [IL]-1 beta, IL-8, and IL-10) have been reported in several small case control studies of patients with frequent episodic or chronic TTH [
         <a href="#rid45">
          45-48
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         However, other studies suggest that tender muscles are likelier due to activated peripheral nociceptors and not sites of ongoing inflammation. As an example, one in vivo study showed normal levels of inflammatory mediators and metabolites related to tender trapezius muscle in patients with chronic TTH during both rest and static exercise [
         <a href="#rid49">
          49
         </a>
         ]. Additional studies are warranted to confirm these findings and to identify causal mechanisms in the development of TTH.
        </p>
        <p>
        </p>
        <p>
         Sustained contraction of pericranial muscles was long believed to be causative in TTH, but this concept is no longer considered valid [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Genetic contributors
         </span>
         <span class="headingEndMark">
          —
         </span>
         However, genetic factors may be more important in the development of chronic TTH than episodic TTH [
         <a href="#rid51">
          51
         </a>
         ]. One study found that first-degree relatives of probands with chronic TTH had more than a threefold increased risk of chronic TTH compared with the general population, suggesting that a genetic factor played a role [
         <a href="#rid17">
          17
         </a>
         ]. Evidence from a genetic study employing complex segregation analysis suggests that chronic TTH has a multifactorial inheritance [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p>
         Hereditary factors seem to play a minor role in the pathogenesis of episodic TTH. Twin studies found no substantial difference in concordance rates for episodic TTH between monozygotic and dizygotic twin pairs, suggesting little if any role for genetic factors [
         <a href="#rid16">
          16,52
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3157407139">
         <span class="h2">
          Risk factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several risk factors have been associated with TTH in cross sectional studies. These include [
         <a href="#rid4">
          4,50,53,54
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Female sex
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Younger age
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fatigue
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sleep disorders
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Migraine history
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Depression history
        </p>
        <p>
        </p>
        <p>
         Educational level has been positively correlated with episodic TTH but negatively correlated with chronic TTH in one population-based telephone survey [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h1">
          CLINICAL FEATURES
         </span>
         <span class="headingEndMark">
          —
         </span>
         The typical presentation of a TTH attack is that of a mild to moderate intensity, bilateral, nonthrobbing headache without other associated features.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Character of head pain
         </strong>
         – The pain in TTH may is typically mild to moderate but may infrequently be severe [
         <a href="#rid55">
          55
         </a>
         ]. Descriptions of TTH pain are characteristically nondescript: "dull," "pressure," "head fullness," "head feels large," or, more descriptively, "like a tight cap," "band-like," or a "heavy weight on my head or shoulders."
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pericranial muscle tenderness
         </strong>
         – Increased pericranial muscle tenderness is the most common abnormal finding on examination in patients with TTH [
         <a href="#rid1">
          1
         </a>
         ]. Muscle tenderness may be identified in the head, neck, or shoulders (ie, pericranial tenderness) chronically and is typically exacerbated during the headache attack.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The presence or absence of pericranial muscle tenderness should be elicited from the history and confirmed on examination by manual palpation [
         <a href="#rid56">
          56,57
         </a>
         ]. Manual palpation is performed by applying firm pressure with the second and third finger and making small rotating movements on the pericranial muscles, including the frontal, temporal, masseter, pterygoid, sternocleidomastoid, splenius, and trapezius muscles [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Triggers
         </strong>
         – Stress and mental strain are reported to be the most common precipitants for TTH [
         <a href="#rid58">
          58
         </a>
         ]. However, the role of these factors in the development of TTH is unclear as they are found at the same frequency in migraine [
         <a href="#rid59">
          59,60
         </a>
         ]. Head and neck movements have also been reported as triggers in some patients with episodic TTH [
         <a href="#rid61">
          61
         </a>
         ]. Other reported triggers for TTH include sleep disturbance, dehydration, alcohol, and sunlight exposure [
         <a href="#rid62">
          62,63
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The causal role of triggering factors is questionable due to the diversity of potential factors and their uncertain relationship to the pathophysiology of TTH. However, identifying and avoiding specific triggers in an individual may help reduce TTH burden. Patients may self-report triggers for TTH or these may be identified with use of a headache diary. (See
         <a class="medical medical_review" href="/z/d/html/3360.html" rel="external">
          "Tension-type headache in adults: Preventive treatment", section on 'Behavioral therapies'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of TTH is made when symptoms are consistent with the typical features of TTH, the diagnostic criteria are fulfilled, and the general and neurologic examinations are normal (other than increased tenderness of pericranial myofascial tissues and the presence of trigger points).
        </p>
        <p>
         There are no diagnostic tests specific for TTH; testing is performed for patients with atypical presentations to identify or exclude alternative entities. (See
         <a class="local">
          'Secondary headaches'
         </a>
         below.)
        </p>
        <p>
         Because of the extensive overlap of TTH symptoms with secondary headaches (eg, medication overuse or structural brain lesions), we suggest clinicians consider the possibility of a secondary headache disorder when patients present for clinical care with presumed TTH. TTH features are often mild and infrequent, unlikely to be a common cause of symptoms among patients presenting for evaluation in clinical practice. (See
         <a class="local">
          'Diagnostic testing'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Diagnostic criteria
         </span>
         <span class="headingEndMark">
          —
         </span>
         The International Classification of Headache Disorders, 3rd edition (ICHD-3) specifies diagnostic criteria for episodic TTH  (
         <a class="graphic graphic_table graphicRef79672" href="/z/d/graphic/79672.html" rel="external">
          table 1
         </a>
         ) and chronic TTH  (
         <a class="graphic graphic_table graphicRef68892" href="/z/d/graphic/68892.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Episodic TTH
         </strong>
         – The ICHD-3 criteria for episodic TTH  (
         <a class="graphic graphic_table graphicRef79672" href="/z/d/graphic/79672.html" rel="external">
          table 1
         </a>
         ) require at least 10 episodes of headache, each lasting 30 minutes to seven days, which fulfill the following conditions:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         At least two of the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Bilateral location
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Pressing or tightening (nonpulsating) quality
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Mild or moderate intensity
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Not aggravated by routine physical activity such as walking or climbing stairs
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Both of the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         No nausea or vomiting
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         No more than one of photophobia or phonophobia
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The infrequent episodic TTH subform is diagnosed if the headache episodes occur on &lt;1 day per month on average (&lt;12 days per year). The frequent episodic TTH subform is diagnosed if the headache episodes occur on 1 to 14 days per month on average (≥12 and &lt;180 days per year).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Chronic TTH
         </strong>
         – The ICHD-3 criteria for chronic TTH  (
         <a class="graphic graphic_table graphicRef68892" href="/z/d/graphic/68892.html" rel="external">
          table 2
         </a>
         ) require headaches lasting hours to days or unremitting, occurring on ≥15 days per month on average for more than three months (≥180 days per year) and fulfilling:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         At least two of the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Bilateral location
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Pressing or tightening (nonpulsating) quality
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Mild or moderate intensity
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Not aggravated by routine physical activity such as walking or climbing stairs
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Both of the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         No more than one of photophobia, phonophobia, or mild nausea
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Neither moderate or severe nausea nor vomiting
        </p>
        <p>
        </p>
        <p>
         Each of the subtypes of TTH is additionally classified as occurring with or without pericranial muscle tenderness [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="local">
          'Clinical features'
         </a>
         above.)
        </p>
        <p>
         Patients may be diagnosed with probable TTH when headache features meet all but one of the ICHD-3 criteria for TTH.
        </p>
        <p>
         The ICHD-3 criteria provide a diagnostic hierarchy for patients whose symptoms fulfill multiple sets of criteria [
         <a href="#rid1">
          1
         </a>
         ]. When a patient has headaches that meet criteria for both TTH and migraine, then migraine supersedes TTH as the diagnosis. Patients who meet criteria for both TTH and probable migraine are considered to have episodic TTH. Patients who meet the criteria for both chronic TTH and medication overuse headache (MOH) are considered to have both conditions; following successful treatment of MOH, the diagnosis should be reevaluated because many patients may be reclassified as having episodic TTH alone.
        </p>
        <p class="headingAnchor" id="H1391840035">
         <span class="h2">
          Distinguishing other primary headaches
         </span>
         <span class="headingEndMark">
          —
         </span>
         The ICHD-3 criteria were designed to distinguish between TTH, migraine, and cluster headache. The diagnostic criteria for TTH can be viewed in contradistinction to criteria that characterize other primary headache disorders. These distinctions can be summarized according to what TTH is
         <strong>
          not
         </strong>
         : localized, throbbing, severe at presentation, aggravated by activity, accompanied by aura, or associated with cranial autonomic symptoms.
        </p>
        <p>
         Some patients with TTH may report symptoms that partially overlap with other headache syndromes, but these features are typically minor when due to TTH. The presence of either photophobia or phonophobia alone (but not both) may occur with TTH. In addition, mild nausea may accompany chronic TTH as long as there is no photophobia or phonophobia. However, there are no auras with TTH, whether visual, language, sensory, motor, or coordination. Similarly, other features typically associated with migraine headache, such as nausea, vomiting, or sensitivity to light and noise, are not characteristic features of episodic TTH. The proportion of TTH associated with cranial autonomic features is currently unknown, but these are uncommon accompaniments in the author's experience.
        </p>
        <p>
         Headache diaries or calendars may help improve the accuracy of reporting the frequency of TTH to help determine the subtype. The distinction between episodic and chronic headache types is complicated by inaccuracies in patient recall of headache frequency. In one large survey study of nearly 16,000 patients with headache, subjects tended to report monthly headache frequency rounded to the nearest five days. Females were more likely to round than males; rounding decreased with increasing age and increased with symptoms of depression [
         <a href="#rid64">
          64
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h2">
          Diagnostic testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Diagnostic testing is warranted to identify secondary cause of headache for patients with symptoms or signs that are atypical for TTH as well as for those with typical TTH symptoms plus an additional historical feature suggestive of a secondary cause of headache  (
         <a class="graphic graphic_table graphicRef141069" href="/z/d/graphic/141069.html" rel="external">
          table 3
         </a>
         ). These include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Headache features atypical for TTH:
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Abrupt onset
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Localized or unilateral
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Severe or progressive in nature
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Throbbing quality
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Aggravated by activity or change in body position (eg, positional)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Associated with neurologic or systemic features (eg, impaired vision, severe nausea, weakness, fever)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Historical features associated with a secondary headache:
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Age &gt;50 years old
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Neoplasm history
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Anticoagulant use
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Trauma
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pregnancy
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Immunosuppressant state
        </p>
        <p>
        </p>
        <p>
         Headache and historical features suggestive of an underlying structural, metabolic, or systemic cause are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/3349.html" rel="external">
          "Evaluation of headache in adults", section on 'Danger signs'
         </a>
         .)
        </p>
        <p>
         Diagnostic testing to exclude alternative causes of headache generally consists of brain imaging. Other testing such as cerebrospinal fluid (CSF) analysis or laboratory testing is reserved for patients with a suspected secondary headache and clinical features suggestive of an infectious or other systemic condition or when neuroimaging is nondiagnostic.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neuroimaging
         </strong>
         – We typically perform brain magnetic resonance imaging (MRI) with contrast to assess for secondary causes of headache. Computed tomography (CT) of the brain with contrast may be performed in emergency settings to exclude conditions such as intracranial hemorrhage or as a less sensitive alternative test in nonemergency settings when MRI is unavailable or contraindicated.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In addition, vascular imaging may be warranted for patients with suspected arterial or venous cause to headache symptoms, such as those with ischemic stroke from carotid dissection, reversible cerebral vasoconstriction syndrome, or cerebral venous thrombosis. Arterial imaging options include MR- or CT-angiography. MR- or CT-venography is used to assess venous structures.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The approach to neuroimaging in adult patients with headache is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/3349.html" rel="external">
          "Evaluation of headache in adults", section on 'Indications for imaging'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other testing
         </strong>
         – Lumbar puncture for CSF analysis is typically performed for patients with suspected secondary causes to exclude conditions such as subarachnoid hemorrhage or meningitis. Laboratory testing, such as erythrocyte sedimentation rate and C-reactive protein, are warranted for patients ≥50 years old with suspected giant cell arteritis. Additional testing for specific suspected secondary causes of headache is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/3349.html" rel="external">
          "Evaluation of headache in adults", section on 'Lumbar puncture'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3349.html" rel="external">
          "Evaluation of headache in adults", section on 'Common clinical scenarios'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Diagnostic testing may be unnecessary for other patients who have characteristic features of TTH, a stable headache pattern for over six months, a normal neurologic examination, and no associated high-risk conditions.
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis of TTH includes other primary headache conditions and secondary headaches that may present with bilateral, nonthrobbing headache attacks. These alternative conditions are typically distinguished from TTH by specific clinical features and/or by results of diagnostic testing. (See
         <a class="local">
          'Diagnostic testing'
         </a>
         above.)
        </p>
        <p>
         Diagnostic challenges may occur when symptoms are atypical or variable, when some clinical features are missing or not reported by patients, when features overlap with other types of headaches, and when patients have multiple headache conditions. Older adults pose unique diagnostic challenges due to physiologic changes associated with aging and medical comorbidities that can increase the risk of secondary and some primary headaches [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Migraine
         </span>
         <span class="headingEndMark">
          —
         </span>
         Migraine may be the most common headache condition in the differential diagnosis of TTH.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Relationships between migraine and TTH
         </strong>
         – Migraine may be mistaken for TTH due to overlapping diagnostic criteria, especially for patients with migraine without aura. Migraine may precipitate or aggravate TTH in individuals who have both types of headache. In addition, migraine and TTH may also occur as independent conditions with shared environmental and lifestyle factors [
         <a href="#rid52">
          52
         </a>
         ]. In a population study that compared clinical characteristics of TTH, the one-year prevalence of TTH was similar for individuals with migraine as for those without a migraine history [
         <a href="#rid60">
          60,66
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Diagnostic challenges occur when patients underreport symptoms by poorly describing them (typically underreporting migraine symptomatology) or when TTH headache symptoms overlap with features suggestive of migraine (eg, severe pain, associated with photophobia or phonophobia).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Features suggestive of migraine
         </strong>
         – The presence of aura is the most characteristic distinguishing feature suggestive of migraine. Other features suggestive of migraine include unilateral pain, pulsatile quality, associated nausea, photophobia and/or phonophobia, and the presence of cutaneous allodynia (eg, discomfort with brushing hair). (See
         <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">
          "Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Clinical features'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Patients with disabling episodic headache are more likely to have migraine than TTH. In one study, 32 percent of patients with an initial diagnosis of episodic TTH were subsequently diagnosed with migraine or probable migraine when headache diaries were reviewed [
         <a href="#rid67">
          67
         </a>
         ]. Individuals with TTH reclassified as having migraine responded to triptans in the study, while persons with episodic TTH not meeting criteria for migraine responded at placebo rates [
         <a href="#rid67">
          67,68
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Unilateral, severe, or throbbing pain can occur in a minority of patients with TTH, presumably when the pain is most intense [
         <a href="#rid69">
          69
         </a>
         ]. Nevertheless, one should be wary of classifying such a headache as TTH rather than probable migraine since underreporting of migraine symptoms is a common problem. Typically, migrainous features are mild or inconstant when present in TTH. (See
         <a class="local">
          'Distinguishing other primary headaches'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Cataloging features of serial headache attacks may help to discriminate between migraine and TTH.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Patients who meet diagnostic criteria for both migraine without aura and TTH
         </strong>
         – Distinguishing episodic TTH from migraine without aura may be difficult. As an example, the diagnosis of probable TTH can be made according to the International Classification of Headache Disorders, 3rd edition (ICHD-3) classification in a patient with a unilateral, severe, nonthrobbing headache that is not aggravated by normal physical activity and has no associated symptoms [
         <a href="#rid1">
          1
         </a>
         ]. This same individual also meets ICHD-3 criteria for probable migraine without aura. In such cases, the diagnosis of migraine and its subtypes supersedes that of TTH and its subtypes.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Patients with a stable pattern of episodic, disabling headache and a normal physical examination should be considered to have migraine in the absence of contradictory evidence [
         <a href="#rid70">
          70
         </a>
         ]. This hypothesis was validated by a study that evaluated 1203 patients visiting a primary practitioner with a complaint of episodic headache [
         <a href="#rid71">
          71
         </a>
         ]. The subjects then recorded their next six headaches in diaries, and each headache was strictly classified according to the original 1988 International Classification of Headache Disorders (ICHD) criteria [
         <a href="#rid72">
          72
         </a>
         ]. Overall, ICHD-defined migraine was present in 94 percent of the subjects (including 76 percent with migraine and 18 percent with probable migraine), while TTH was diagnosed in 3 percent.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3205585339">
         <span class="h2">
          Medication overuse headache
         </span>
         <span class="headingEndMark">
          —
         </span>
         Medication overuse headache (MOH) is a commonly encountered type of headache disorder with clinical features that can often be nondescript and mimic chronic TTH. The development of MOH is typically preceded by an episodic headache disorder, usually migraine or TTH. However, MOH may be distinguished by the presence of frequent or daily headaches that occur despite, or because of, the regular use of headache medications. Withdrawal and detoxification of the overused medication improves symptoms due to MOH. (See
         <a class="medical medical_review" href="/z/d/html/3341.html" rel="external">
          "Medication overuse headache: Treatment and prognosis"
         </a>
         .)
        </p>
        <p>
         MOH may occur as a result of TTH, especially when management is suboptimal or preventive treatment ineffective. Observational studies have found patients with MOH associated with TTH may have stronger withdrawal symptoms and higher relapse rates than those with MOH associated with other primary headache conditions at both one- and four-year prospective follow-up [
         <a href="#rid73">
          73,74
         </a>
         ]. This is probably due, at least in part, to the withdrawal patterns particular to the medications used for different types of headache, since overuse of mixed analgesics (typically used for TTH) is associated with a higher relapse rate than overuse of triptans (typically used for migraine) after drug withdrawal.
        </p>
        <p class="headingAnchor" id="H703830771">
         <span class="h2">
          Other primary headache disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several less common primary headache syndromes may mimic TTH. Specific clinical features may help to identify these alternative conditions.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hemicrania continua
         </strong>
         – Patients with chronic TTH may have frequent or continuous headaches similar to those with hemicrania continua. However, patients with hemicrania continua also have cranial autonomic symptoms (eg, conjunctival injection, rhinorrhea, facial sweating, ptosis) and typically report a sense of restlessness during severe headache symptoms. In addition, hemicrania continua responds to therapeutic doses of
         <a class="drug drug_general" data-topicid="8559" href="/z/d/drug information/8559.html" rel="external">
          indomethacin
         </a>
         . (See
         <a class="medical medical_review" href="/z/d/html/3342.html" rel="external">
          "Hemicrania continua"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hypnic headache
         </strong>
         – The specific features of hypnic headache are often bilateral, dull in character, and moderate in intensity, similar to patients with TTH. Unlike TTH, hypnic headache is uniquely characterized by onset during sleep. (See
         <a class="medical medical_review" href="/z/d/html/3328.html" rel="external">
          "Hypnic headache"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          New daily persistent headache
         </strong>
         – Patients with new daily persistent headache may report somewhat nondescript headaches consistent with clinical features of TTH. However, these headaches are characterized by a specific, recalled date of onset followed by unremitting persistence of the headache. (See
         <a class="medical medical_review" href="/z/d/html/3343.html" rel="external">
          "New daily persistent headache"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          External pressure headache
         </strong>
         – Headache may also be due to external stimuli that exert pressure on the head or neck. Such headaches may be suspected when headaches occur in the setting of wearing tight-fitting helmets or goggles or traction on the hair from a ponytail or braiding [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h2">
          Secondary headaches
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with headaches due to a secondary headache syndrome may present diagnostic challenges because symptoms may overlap with TTH. Secondary headaches may be associated with specific clinical features or examination findings that are atypical for both episodic and chronic TTH  (
         <a class="graphic graphic_table graphicRef141069" href="/z/d/graphic/141069.html" rel="external">
          table 3
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/3349.html" rel="external">
          "Evaluation of headache in adults", section on 'Specific features suggesting a secondary headache source'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h3">
          Brain tumor headache
         </span>
         <span class="headingEndMark">
          —
         </span>
         Brain tumor headache frequently mimics TTH. However, only a minority of patients presenting for evaluation with headaches have a brain tumor. Specific clinical characteristics more commonly associated with tumors can help identify these cases. These include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         New headache at age &gt;50 years
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         History of cancer
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Progressive symptoms
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Abnormal neurologic examination
        </p>
        <p>
        </p>
        <p>
         The features of headache associated with a brain tumor are generally nonspecific and vary widely with tumor location, size, and rate of growth. The headache is usually bilateral but can be on the side of the tumor. (See
         <a class="medical medical_review" href="/z/d/html/14113.html" rel="external">
          "Brain tumor headache", section on 'Clinical features'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H24">
         <span class="h3">
          Sinus symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         "Sinus headache" is commonly diagnosed by clinicians and self-diagnosed by patients, but acute or chronic sinusitis appears to be an uncommon cause of recurrent headaches, and many of these patients actually have migraine or, less often, TTH [
         <a href="#rid75">
          75,76
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3349.html" rel="external">
          "Evaluation of headache in adults", section on 'Sinus symptoms'
         </a>
         .)
        </p>
        <p>
         The occurrence of nasal symptoms associated with headache in the region of the sinuses, without fever or purulent nasal discharge, should prompt an evaluation for both sinusitis and primary headaches, including TTH [
         <a href="#rid75">
          75,77
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H25">
         <span class="h3">
          Cervicogenic headache
         </span>
         <span class="headingEndMark">
          —
         </span>
         The pain with cervicogenic headache can mimic that of TTH, including nonthrobbing pain, moderate intensity, and associated pericranial muscle tenderness. However, symptoms with cervicogenic headache are unilateral, often associated with restricted range of motion of or pain exacerbation with neck movement [
         <a href="#rid78">
          78
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3354.html" rel="external">
          "Cervicogenic headache"
         </a>
         .)
        </p>
        <p>
         In addition, a practical approach for establishing the diagnosis of cervicogenic headache relies on the use of controlled anesthetic blocks of cervical structures or their nerve supply. These diagnostic anesthetic blocks are posited to pinpoint sources of pain in the neck when they provide relief of pain. (See
         <a class="medical medical_review" href="/z/d/html/3354.html" rel="external">
          "Cervicogenic headache", section on 'Diagnostic anesthetic blockade'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3329463621">
         <span class="h3">
          Idiopathic intracranial hypertension
         </span>
         <span class="headingEndMark">
          —
         </span>
         Headache symptoms due to idiopathic intracranial hypertension (IIH, also called pseudotumor cerebri) are nonspecific. The presence of additional symptoms associated with IIH may suggest the diagnosis, including visual obscurations or diplopia, tinnitus, or back pain. Papilledema may be identified on examination. The diagnosis of IIH is made by documenting elevated intracranial pressure in the setting of normal cerebrospinal fluid composition. (See
         <a class="medical medical_review" href="/z/d/html/5257.html" rel="external">
          "Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H26">
         <span class="h3">
          Others
         </span>
         <span class="headingEndMark">
          —
         </span>
         Less common alternative causes of headache in patients with suspected TTH include rare conditions as well as more common conditions that uncommonly present with isolated nonspecific headaches, mimicking TTH. These entities are typically identified by the presence of specific features that are atypical for TTH, including historical details, abnormal findings on clinical examination or diagnostic testing, or nonresponsiveness to TTH treatment.
        </p>
        <p>
         These conditions include [
         <a href="#rid50">
          50,79
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Spontaneous intracranial hypotension
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chiari I malformation
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Subdural hematoma
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cerebral venous thrombosis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ischemic stroke
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Giant cell arteritis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Obstructive sleep apnea
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2635975272">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/110285.html" rel="external">
          "Society guideline links: Migraine and other primary headache disorders"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1671419">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/15440.html" rel="external">
          "Patient education: Headaches in adults (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (See
         <a class="medical medical_patient" href="/z/d/html/719.html" rel="external">
          "Patient education: Headache causes and diagnosis in adults (Beyond the Basics)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H27">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology
         </strong>
         – Tension-type headache (TTH) is the most prevalent type of primary headache in the general population with a worldwide prevalence estimated to be 26 percent. The prevalence of TTH sharply increases during adolescence, peaks in the fourth decade, and gradually decreases thereafter. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features
         </strong>
         – The typical presentation of a TTH attack is that of a mild to moderate intensity, bilateral, nonthrobbing headache without other associated features. Increased pericranial muscle tenderness is the most common abnormal finding on examination of patients with TTH. (See
         <a class="local">
          'Clinical features'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of TTH is made when symptoms are consistent with the typical features of TTH, the diagnostic criteria are fulfilled, and the general and neurologic examinations are normal, other than the presence of increased tenderness of pericranial muscle tenderness. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The International Classification of Headache Disorders, 3rd edition (ICHD-3) specifies diagnostic criteria for episodic TTH, both infrequent and frequent subforms,  (
         <a class="graphic graphic_table graphicRef79672" href="/z/d/graphic/79672.html" rel="external">
          table 1
         </a>
         ) and chronic TTH  (
         <a class="graphic graphic_table graphicRef68892" href="/z/d/graphic/68892.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'Diagnostic criteria'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Infrequent episodic TTH – headaches occur &lt;1 day a month on average
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Frequent episodic TTH – headaches occur 1 to 14 days a month on average (for &gt;3 months)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Chronic TTH – headaches occur ≥15 days a month on average (for &gt;3 months)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Each of the subtypes is additionally subclassified as occurring with or without pericranial muscle tenderness.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnostic testing for atypical presentations
         </strong>
         – Diagnostic testing is warranted to identify secondary cause of headache for patients with symptoms or signs that are atypical for TTH as well as for those with typical TTH symptoms plus an additional historical feature suggestive of a secondary cause of headache  (
         <a class="graphic graphic_table graphicRef141069" href="/z/d/graphic/141069.html" rel="external">
          table 3
         </a>
         ). (See
         <a class="local">
          'Diagnostic testing'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Diagnostic testing to exclude alternative causes of headache generally consists of brain imaging, typically brain MRI with contrast. Other testing for selected patients with suspected alternative conditions may include cerebrovascular imaging, lumbar puncture, and laboratory testing.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis
         </strong>
         – The differential diagnosis of TTH includes other primary headache conditions and secondary headaches that may present with bilateral, nonthrobbing headache attacks. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Primary headache disorders
         </strong>
         – The most common headache disorders that may mimic TTH include migraine and medication overuse headache. Other primary headache disorders in the differential diagnosis include hemicrania continua, hypnic headache, new daily persistent headache, and external pressure headache. (See
         <a class="local">
          'Migraine'
         </a>
         above and
         <a class="local">
          'Medication overuse headache'
         </a>
         above and
         <a class="local">
          'Other primary headache disorders'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Secondary headaches
         </strong>
         – Several secondary headaches due to an underlying structural cause may present with nonspecific headaches that can mimic TTH. Common secondary headaches include (see
         <a class="local">
          'Secondary headaches'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Brain tumor headache
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Sinus symptoms
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Cervicogenic headache
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Idiopathic intracranial hypertension
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         These alternative conditions may be distinguished by specific clinical features and/or by results of diagnostic testing.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jensen RH. Tension-Type Headache - The Normal and Most Prevalent Headache. Headache 2018; 58:339.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol 2017; 16:877.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ashina S, Mitsikostas DD, Lee MJ, et al. Tension-type headache. Nat Rev Dis Primers 2021; 7:24.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018; 17:954.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA 1998; 279:381.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Russell MB, Levi N, Saltyte-Benth J, Fenger K. Tension-type headache in adolescents and adults: a population based study of 33,764 twins. Eur J Epidemiol 2006; 21:153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bendtsen L, Jensen R. Tension-type headache: the most common, but also the most neglected, headache disorder. Curr Opin Neurol 2006; 19:305.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population--a prevalence study. J Clin Epidemiol 1991; 44:1147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Russell MB. Tension-type headache in 40-year-olds: a Danish population-based sample of 4000. J Headache Pain 2005; 6:441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang SJ, Liu HC, Fuh JL, et al. Prevalence of headaches in a Chinese elderly population in Kinmen: age and gender effect and cross-cultural comparisons. Neurology 1997; 49:195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Couch JR. The long-term prognosis of tension-type headache. Curr Pain Headache Rep 2005; 9:436.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ashina S, Buse DC, Bjorner JB, et al. Health-related quality of life in tension-type headache: a population-based study. Scand J Pain 2021; 21:778.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol 2008; 7:354.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jensen R. Peripheral and central mechanisms in tension-type headache: an update. Cephalalgia 2003; 23 Suppl 1:49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ulrich V, Gervil M, Olesen J. The relative influence of environment and genes in episodic tension-type headache. Neurology 2004; 62:2065.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Russell MB, Ostergaard S, Bendtsen L, Olesen J. Familial occurrence of chronic tension-type headache. Cephalalgia 1999; 19:207.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Russell MB, Iselius L, Ostergaard S, Olesen J. Inheritance of chronic tension-type headache investigated by complex segregation analysis. Hum Genet 1998; 102:138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bendtsen L. Central and peripheral sensitization in tension-type headache. Curr Pain Headache Rep 2003; 7:460.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bezov D, Ashina S, Jensen R, Bendtsen L. Pain perception studies in tension-type headache. Headache 2011; 51:262.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bendtsen L, Fumal A, Schoenen J. Tension-type headache: mechanisms. Handb Clin Neurol 2010; 97:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schmidt-Wilcke T, Leinisch E, Straube A, et al. Gray matter decrease in patients with chronic tension type headache. Neurology 2005; 65:1483.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bendtsen L, Fernández-de-la-Peñas C. The role of muscles in tension-type headache. Curr Pain Headache Rep 2011; 15:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zagami AS. Pathophysiology of migraine and tension-type headache. Curr Opin Neurol 1994; 7:272.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ashina M. Neurobiology of chronic tension-type headache. Cephalalgia 2004; 24:161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bendtsen L. Central sensitization in tension-type headache--possible pathophysiological mechanisms. Cephalalgia 2000; 20:486.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cathcart S, Winefield AH, Lushington K, Rolan P. Noxious inhibition of temporal summation is impaired in chronic tension-type headache. Headache 2010; 50:403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ashina S, Bendtsen L, Ashina M, et al. Generalized hyperalgesia in patients with chronic tension-type headache. Cephalalgia 2006; 26:940.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ozkul Y, Ay H. Habituation of sympathetic skin response in migraine and tension type headache. Auton Neurosci 2007; 134:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Langemark M, Jensen K, Jensen TS, Olesen J. Pressure pain thresholds and thermal nociceptive thresholds in chronic tension-type headache. Pain 1989; 38:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schoenen J, Bottin D, Hardy F, Gerard P. Cephalic and extracephalic pressure pain thresholds in chronic tension-type headache. Pain 1991; 47:145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bendtsen L, Jensen R, Olesen J. Decreased pain detection and tolerance thresholds in chronic tension-type headache. Arch Neurol 1996; 53:373.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schoenen J. Depression in tension-type headache sufferers: bystander or villain? Pain 2004; 111:225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sandrini G, Rossi P, Milanov I, et al. Abnormal modulatory influence of diffuse noxious inhibitory controls in migraine and chronic tension-type headache patients. Cephalalgia 2006; 26:782.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pielsticker A, Haag G, Zaudig M, Lautenbacher S. Impairment of pain inhibition in chronic tension-type headache. Pain 2005; 118:215.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ashina M, Bendtsen L, Jensen R, Olesen J. Nitric oxide-induced headache in patients with chronic tension-type headache. Brain 2000; 123 ( Pt 9):1830.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ashina M, Lassen LH, Bendtsen L, et al. Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial. Lancet 1999; 353:287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Tommaso M, Ceci E, Pica C, et al. Serum levels of N-acetyl-aspartate in migraine and tension-type headache. J Headache Pain 2012; 13:389.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fischer M, Wille G, Klien S, et al. Brain-derived neurotrophic factor in primary headaches. J Headache Pain 2012; 13:469.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernández-de-Las-Peñas C, Cuadrado ML, Pareja JA. Myofascial trigger points, neck mobility, and forward head posture in episodic tension-type headache. Headache 2007; 47:662.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernández-de-Las-Peñas C, Alonso-Blanco C, Cuadrado ML, et al. Myofascial trigger points and their relationship to headache clinical parameters in chronic tension-type headache. Headache 2006; 46:1264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernández-de-las-Peñas C, Alonso-Blanco C, Cuadrado ML, et al. Trigger points in the suboccipital muscles and forward head posture in tension-type headache. Headache 2006; 46:454.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Caamaño-Barrios LH, Galán-Del-Río F, Fernández-de-Las-Peñas C, et al. Widespread Pressure Pain Sensitivity over Nerve Trunk Areas in Women with Frequent Episodic Tension-Type Headache as a Sign of Central Sensitization. Pain Med 2020; 21:1408.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ashina S, Bendtsen L, Ashina M. Pathophysiology of tension-type headache. Curr Pain Headache Rep 2005; 9:415.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Della Vedova C, Cathcart S, Dohnalek A, et al. Peripheral interleukin-1ß levels are elevated in chronic tension-type headache patients. Pain Res Manag 2013; 18:301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koçer A, Koçer E, Memişoğullari R, et al. Interleukin-6 levels in tension headache patients. Clin J Pain 2010; 26:690.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Domingues RB, Duarte H, Rocha NP, Teixeira AL. Increased serum levels of interleukin-8 in patients with tension-type headache. Cephalalgia 2015; 35:801.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trigo J, García-Azorín D, Sierra-Mencía Á, et al. Cytokine and interleukin profile in patients with headache and COVID-19: A pilot, CASE-control, study on 104 patients. J Headache Pain 2021; 22:51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ashina M, Stallknecht B, Bendtsen L, et al. Tender points are not sites of ongoing inflammation -in vivo evidence in patients with chronic tension-type headache. Cephalalgia 2003; 23:109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steel SJ, Robertson CE, Whealy MA. Current Understanding of the Pathophysiology and Approach to Tension-Type Headache. Curr Neurol Neurosci Rep 2021; 21:56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernández-de-Las-Peñas C, Ambite-Quesada S, Palacios-Ceña M, et al. Catechol-O-Methyltransferase (COMT) rs4680 Val158Met Polymorphism is Associated With Widespread Pressure Pain Sensitivity and Depression in Women With Chronic, but not Episodic, Tension-Type Headache. Clin J Pain 2019; 35:345.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ligthart L, Huijgen A, Willemsen G, et al. Are Migraine and Tension-Type Headache Genetically Related? An Investigation of Twin Family Data. Twin Res Hum Genet 2018; 21:112.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rains JC, Davis RE, Smitherman TA. Tension-type headache and sleep. Curr Neurol Neurosci Rep 2015; 15:520.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang SJ, Fuh JL, Lu SR, Juang KD. Outcomes and predictors of chronic daily headache in adolescents: a 2-year longitudinal study. Neurology 2007; 68:591.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lyngberg AC, Rasmussen BK, Jørgensen T, Jensen R. Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey. Eur J Epidemiol 2005; 20:243.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sandrini G, Antonaci F, Pucci E, et al. Comparative study with EMG, pressure algometry and manual palpation in tension-type headache and migraine. Cephalalgia 1994; 14:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jensen R, Fuglsang-Frederiksen A. Quantitative surface EMG of pericranial muscles. Relation to age and sex in a general population. Electroencephalogr Clin Neurophysiol 1994; 93:175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spierings EL, Ranke AH, Honkoop PC. Precipitating and aggravating factors of migraine versus tension-type headache. Headache 2001; 41:554.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rasmussen BK. Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to lifestyle. Pain 1993; 53:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ulrich V, Russell MB, Jensen R, Olesen J. A comparison of tension-type headache in migraineurs and in non-migraineurs: a population-based study. Pain 1996; 67:501.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karli N, Zarifoglu M, Calisir N, Akgoz S. Comparison of pre-headache phases and trigger factors of migraine and episodic tension-type headache: do they share similar clinical pathophysiology? Cephalalgia 2005; 25:444.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pellegrino ABW, Davis-Martin RE, Houle TT, et al. Perceived triggers of primary headache disorders: A meta-analysis. Cephalalgia 2018; 38:1188.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang J, Huang Q, Li N, et al. Triggers of migraine and tension-type headache in China: a clinic-based survey. Eur J Neurol 2013; 20:689.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Houle TT, Turner DP, Houle TA, et al. Rounding behavior in the reporting of headache frequency complicates headache chronification research. Headache 2013; 53:908.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berk T, Ashina S, Martin V, et al. Diagnosis and Treatment of Primary Headache Disorders in Older Adults. J Am Geriatr Soc 2018; 66:2408.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rasmussen BK, Jensen R, Schroll M, Olesen J. Interrelations between migraine and tension-type headache in the general population. Arch Neurol 1992; 49:914.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lipton RB, Cady RK, Stewart WF, et al. Diagnostic lessons from the spectrum study. Neurology 2002; 58:S27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lipton RB, Stewart WF, Cady R, et al. 2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study. Headache 2000; 40:783.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rasmussen BK. Epidemiology of headache. Cephalalgia 1995; 15:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dowson AJ. Assessing the impact of migraine. Curr Med Res Opin 2001; 17:298.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tepper SJ, Dahlöf CG, Dowson A, et al. Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study. Headache 2004; 44:856.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 1988; 8 Suppl 7:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katsarava Z, Limmroth V, Finke M, et al. Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology 2003; 60:1682.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katsarava Z, Muessig M, Dzagnidze A, et al. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 2005; 25:12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cady RK, Schreiber CP. Sinus headache or migraine? Considerations in making a differential diagnosis. Neurology 2002; 58:S10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robblee J, Secora KA. Debunking Myths: Sinus Headache. Curr Neurol Neurosci Rep 2021; 21:42.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bigal ME, Lipton RB. Tension-type headache: classification and diagnosis. Curr Pain Headache Rep 2005; 9:423.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bendtsen L, Evers S, Linde M, et al. EFNS guideline on the treatment of tension-type headache - report of an EFNS task force. Eur J Neurol 2010; 17:1318.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crystal SC, Robbins MS. Tension-type headache mimics. Curr Pain Headache Rep 2011; 15:459.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 3357 Version 26.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29368949" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28295304" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Tension-Type Headache - The Normal and Most Prevalent Headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28931491" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33767185" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30353868" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9459472" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Epidemiology of tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16518684" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Tension-type headache in adolescents and adults: a population based study of 33,764 twins.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16702840" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Tension-type headache: the most common, but also the most neglected, headache disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1941010" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Epidemiology of headache in a general population--a prevalence study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16388338" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Tension-type headache in 40-year-olds: a Danish population-based sample of 4000.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9222190" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Prevalence of headaches in a Chinese elderly population in Kinmen: age and gender effect and cross-cultural comparisons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16282045" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : The long-term prognosis of tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33544560" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Health-related quality of life in tension-type headache: a population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18339350" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Epidemiology and comorbidity of headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12699459" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Peripheral and central mechanisms in tension-type headache: an update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15184615" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : The relative influence of environment and genes in episodic tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10376164" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Familial occurrence of chronic tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9521579" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Inheritance of chronic tension-type headache investigated by complex segregation analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14604505" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Central and peripheral sensitization in tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21029081" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Pain perception studies in tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20816435" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Tension-type headache: mechanisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16275843" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Gray matter decrease in patients with chronic tension type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21735049" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : The role of muscles in tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8081522" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Pathophysiology of migraine and tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15009009" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Neurobiology of chronic tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11037746" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Central sensitization in tension-type headache--possible pathophysiological mechanisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19817882" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Noxious inhibition of temporal summation is impaired in chronic tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16886930" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Generalized hyperalgesia in patients with chronic tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17395550" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Habituation of sympathetic skin response in migraine and tension type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2780074" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Pressure pain thresholds and thermal nociceptive thresholds in chronic tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1762808" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Cephalic and extracephalic pressure pain thresholds in chronic tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8929161" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Decreased pain detection and tolerance thresholds in chronic tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15363863" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Depression in tension-type headache sufferers: bystander or villain?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16776692" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Abnormal modulatory influence of diffuse noxious inhibitory controls in migraine and chronic tension-type headache patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16202520" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Impairment of pain inhibition in chronic tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10960046" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Nitric oxide-induced headache in patients with chronic tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9929022" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22527035" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Serum levels of N-acetyl-aspartate in migraine and tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22584531" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Brain-derived neurotrophic factor in primary headaches.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17501847" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Myofascial trigger points, neck mobility, and forward head posture in episodic tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16942471" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Myofascial trigger points and their relationship to headache clinical parameters in chronic tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16618263" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Trigger points in the suboccipital muscles and forward head posture in tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31329227" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Widespread Pressure Pain Sensitivity over Nerve Trunk Areas in Women with Frequent Episodic Tension-Type Headache as a Sign of Central Sensitization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16282042" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Pathophysiology of tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23957020" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Peripheral interleukin-1ßlevels are elevated in chronic tension-type headache patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20664340" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Interleukin-6 levels in tension headache patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25416323" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Increased serum levels of interleukin-8 in patients with tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34088273" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Cytokine and interleukin profile in patients with headache and COVID-19: A pilot, CASE-control, study on 104 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12603367" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Tender points are not sites of ongoing inflammation -in vivo evidence in patients with chronic tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34599406" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Current Understanding of the Pathophysiology and Approach to Tension-Type Headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30614828" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Catechol-O-Methyltransferase (COMT) rs4680 Val158Met Polymorphism is Associated With Widespread Pressure Pain Sensitivity and Depression in Women With Chronic, but not Episodic, Tension-Type Headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29582723" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Are Migraine and Tension-Type Headache Genetically Related? An Investigation of Twin Family Data.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25475495" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Tension-type headache and sleep.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17182975" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Outcomes and predictors of chronic daily headache in adolescents: a 2-year longitudinal study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15921042" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7697707" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Comparative study with EMG, pressure algometry and manual palpation in tension-type headache and migraine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7515793" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Quantitative surface EMG of pericranial muscles. Relation to age and sex in a general population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11437890" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Precipitating and aggravating factors of migraine versus tension-type headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8316392" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to lifestyle.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8951947" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : A comparison of tension-type headache in migraineurs and in non-migraineurs: a population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15910569" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Comparison of pre-headache phases and trigger factors of migraine and episodic tension-type headache: do they share similar clinical pathophysiology?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28825314" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Perceived triggers of primary headache disorders: A meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23356519" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Triggers of migraine and tension-type headache in China: a clinic-based survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23721238" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Rounding behavior in the reporting of headache frequency complicates headache chronification research.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30251385" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Diagnosis and Treatment of Primary Headache Disorders in Older Adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1520080" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Interrelations between migraine and tension-type headache in the general population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12011271" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Diagnostic lessons from the spectrum study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11135021" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : 2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7758098" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Epidemiology of headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11922404" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Assessing the impact of migraine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15447694" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3048700" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12771266" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Rates and predictors for relapse in medication overuse headache: a 1-year prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15606564" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Medication overuse headache: rates and predictors for relapse in a 4-year prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12011268" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Sinus headache or migraine? Considerations in making a differential diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34148140" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Debunking Myths: Sinus Headache.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16282043" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Tension-type headache: classification and diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20482606" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : EFNS guideline on the treatment of tension-type headache - report of an EFNS task force.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21976030" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Tension-type headache mimics.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
